ArrayExpress Uploaderarrayexpress_sidhumanbreast cancer surgical specimenNo Treatmentbasal26ERnegHER2negbreast cancer surgical specimenNo TreatmentLumA25ERposHER2negbreast cancer surgical specimenNo TreatmentLumA24ERposHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapynormal23ERnegHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapybasal22ERnegHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapybasal20ERnegHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapybasal19ERnegHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapyHer218ERnegHER2posbreast cancer surgical specimenNo Treatmentbasal17ERnegHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapyLumA16ERposHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapynormal15ERposHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapynormal14ERposHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapyLumA13ERposHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapybasal12ERnegHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapybasal11ERnegHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapybasal10ERnegHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapynormal9ERposHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapynormal8ERnegHER2posbreast cancer surgical specimenpost-neoadjuvant systemic therapyLumB7ERposHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapyLumA6ERposHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapynormal5ERnegHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapynormal4ERnegHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapyLumA3ERposHER2negbreast cancer surgical specimenpost-neoadjuvant systemic therapyLumA2ERposHER2negbreast cancer tumorpost-neoadjuvant systemic therapybasal1ERnegHER2posbreast cancer tumorNo Treatmentbasal26ERnegHER2negbreast cancer tumorNo TreatmentLumA25ERposHER2negbreast cancer tumorNo TreatmentLumA24ERposHER2negbreast cancer tumorpre-neoadjuvant systemic therapynormal23ERnegHER2negbreast cancer tumorpre-neoadjuvant systemic therapybasal22ERnegHER2negbreast cancer tumorpre-neoadjuvant systemic therapybasal20ERposHER2negbreast cancer tumorpre-neoadjuvant systemic therapybasal19ERnegHER2negbreast cancer tumorpre-neoadjuvant systemic therapyHer218ERnegHER2posbreast cancer tumorNo Treatmentbasal17ERnegHER2negbreast cancer tumorpre-neoadjuvant systemic therapyLumA16ERposHER2negbreast cancer tumorpre-neoadjuvant systemic therapyLumA15ERposHER2negbreast cancer tumorpre-neoadjuvant systemic therapybasal14ERnegHER2negbreast cancer tumorpre-neoadjuvant systemic therapyLumA13ERposHER2negbreast cancer tumorpre-neoadjuvant systemic therapybasal12ERnegHER2negbreast cancer tumorpre-neoadjuvant systemic therapynormal11ERnegHER2negbreast cancer tumorpre-neoadjuvant systemic therapybasal10ERnegHER2negbreast cancer tumorpre-neoadjuvant systemic therapyLumA9ERposHER2negbreast cancer tumorpre-neoadjuvant systemic therapybasal8ERnegHER2posbreast cancer tumorpre-neoadjuvant systemic therapyHer27ERposHER2negbreast cancer tumorpre-neoadjuvant systemic therapyLumA6ERposHER2negbreast cancer tumorpre-neoadjuvant systemic therapyHer25ERnegHER2posbreast cancer tumorpre-neoadjuvant systemic therapybasal4ERnegHER2negbreast cancer tumorpre-neoadjuvant systemic therapyLumA3ERposHER2negbreast cancer tumorpre-neoadjuvant systemic therapyLumA2ERposHER2negbreast cancer tumorpre-neoadjuvant systemic therapybasal1ERnegHER2neg126503The behavior of breast cancers and their response to neoadjuvant systemic therapy depend on their phenotype which is to a large extent...22235097E-GEOD-32072/profile/8773/arrayexpressuploader650breastcancercellDec.12, 2014FalseE-GEOD-32072_A-AFFY-33expression-data-from-breast-cancer-fna-and-surgicaExpression data from breast cancer FNA and surgical specimens from patientsJun.18, 2014The behavior of breast cancers and their response to neoadjuvant systemic therapy depend on their phenotype which is to a large extent determined by gene expression programs within the cancer cell. The purpose of the analysis was to compare matched gene expression profiles of pretreatment cancer with post-neoadjuvant systemic therapy, residual cancer. Pre-treatment FNA from primary tumors or post-treatment surgical specimens were obtained and RNA extracted and hybridized to afymetrix microarrays according to manufacturer protocol.http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-32072http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-32072/samples/